Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aziz Zaanan

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
Plos One|May 27, 2015
Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II TrialAmélie Anota, Guillaume Mouillet, Isabelle Trouilloud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2017
Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)Fanny Garlan, Pierre Laurent-Puig, David Sefrioui, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2014
ERBB2 gene as a potential therapeutic target in small bowel adenocarcinomaAnais Laforest, Thomas Aparicio, Aziz Zaanan, et al.
Ebiomedicine|March 3, 2019
Comparison of three lymph node staging schemes for predicting the outcome in patients with small bowel adenocarcinoma: A population-based cohort and international multicentre cohort studyYang-Yang Zhou, Xiao-Jing Du, Chi-Hao Zhang, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 11, 2018
Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)Aziz Zaanan, Olivier Bouché, Leonor Benhaim, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 7, 2013
Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohortSimon Pernot, Emmanuel Mitry, Emmanuelle Samalin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2016
Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre studyBertrand Brieau, Claire Auzolle, Astrid Pozet, et al.
International Journal of Molecular Sciences|October 29, 2025
Plasma Protein Biomarkers to Detect Early Gastric Preneoplasia and Cancer: A Prospective StudyQuentin Giai Gianetto, Valérie Michel, Thibaut Douché, et al.
JAMA Oncology|January 16, 2016
Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 TrialJulien Taieb, Aziz Zaanan, Karine Le Malicot, et al.
JCO Precision Oncology|February 9, 2022
<i>ERBB3</i>-Activating Mutations in Small Bowel AdenocarcinomasLuc Cabel, Thomas Aparicio, Ivan Bieche, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Plos One|May 27, 2015
Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II TrialAmélie Anota, Guillaume Mouillet, Isabelle Trouilloud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2017
Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)Fanny Garlan, Pierre Laurent-Puig, David Sefrioui, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2014
ERBB2 gene as a potential therapeutic target in small bowel adenocarcinomaAnais Laforest, Thomas Aparicio, Aziz Zaanan, et al.
Ebiomedicine|March 3, 2019
Comparison of three lymph node staging schemes for predicting the outcome in patients with small bowel adenocarcinoma: A population-based cohort and international multicentre cohort studyYang-Yang Zhou, Xiao-Jing Du, Chi-Hao Zhang, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 11, 2018
Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)Aziz Zaanan, Olivier Bouché, Leonor Benhaim, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 7, 2013
Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohortSimon Pernot, Emmanuel Mitry, Emmanuelle Samalin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2016
Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre studyBertrand Brieau, Claire Auzolle, Astrid Pozet, et al.
International Journal of Molecular Sciences|October 29, 2025
Plasma Protein Biomarkers to Detect Early Gastric Preneoplasia and Cancer: A Prospective StudyQuentin Giai Gianetto, Valérie Michel, Thibaut Douché, et al.
JAMA Oncology|January 16, 2016
Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 TrialJulien Taieb, Aziz Zaanan, Karine Le Malicot, et al.
JCO Precision Oncology|February 9, 2022
<i>ERBB3</i>-Activating Mutations in Small Bowel AdenocarcinomasLuc Cabel, Thomas Aparicio, Ivan Bieche, et al.
Pageof 14